Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 789 of 6351
-
New shot could cut bleeding in Tough-to-Treat hemophilia
Disease control OngoingThe purpose of this study is to show that KN057 can prevent bleeds in patients with haemophilia A or B with inhibitors and is safe to use. Successfully screened participants will be randomly assigned to KN057 Prophylaxis (Arm 1) versus No Prophylaxis (Arm 2) at a ratio of 2:1. Pa…
Phase 3 • Sponsor: Suzhou Alphamab Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:08 UTC
-
Oxygen therapy may help hospitalized colitis patients avoid surgery
Disease control Recruiting nowChronic intestinal hypoxia and accompanying mucosal inflammation is a hallmark of ulcerative colitis (UC). Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen under increased atmospheric pressure to increase tissue oxygenation. Two small prospective randomized control…
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Rebuilding life after stroke: can occupational therapy restore daily independence?
Symptom relief CompletedThe study aims to recruit and enroll 25 participants who meet specific criteria, which will be communicated to potential participants, along with information about the study\'s goals, time commitments, benefits, and risks. Participants can ask questions and receive consent fo…
Sponsor: Texas Woman's University • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Could a gentle nerve zap curb explosive outbursts in Prader-Willi syndrome?
Symptom relief OngoingThe goal of the VNS4PWS clinical study is to test the efficacy, safety, and acceptability of transcutaneous vagus nerve stimulation (tVNS) treatment in people with PWS.
Phase 3 • Sponsor: Foundation for Prader-Willi Research • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New hope for hard-to-treat ovarian cancer: targeted drug shows promise in early trial
Disease control OngoingThis is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with recurrent or persistent platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancers.
Phase 2 • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Simple blood test could spot liver cancer sooner in at-risk patients
Diagnosis Recruiting nowPatients with liver cirrhosis are at high risk of developing hepatocellular carcinoma (HCC) which implies significant mortality. At present current surveillance methods detect hepatocellular carcinomas at a late stage resulting in few treatment options for patients and, in the ma…
Sponsor: Manchester University NHS Foundation Trust • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New stroke drug enters final testing phase – could improve recovery
Disease control Recruiting nowThis is a prospective, multicenter, randomized, double-blind, parallel, phase IV study designed to evaluate the safety and efficacy of sovateltide (PMZ-1620, IRL-1620) as a potential treatment for cerebral ischemic stroke.
Phase 4 • Sponsor: Pharmazz, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Microdosing magic mushrooms: could tiny psilocybin doses soothe End-of-Life anxiety?
Symptom relief OngoingThe goal of this multi-centre phase I/II open-label, single-arm study is to determine the safety, feasibility, therapeutic dose, and preliminary efficacy of psilocybin microdosing to treat psychological distress among patients with advanced illness. Forty patients will receive ps…
Phase 1/2 • Sponsor: Ottawa Hospital Research Institute • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Wearable sensor could unmask hidden blood sugar chaos in stomach paralysis
Knowledge-focused Recruiting nowA pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.
Sponsor: Samita Garg • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Gene therapy trial hopes to tackle rare Autism-Linked condition
Disease control Recruiting nowThis is a Phase 1/2, first in human, open-label, dose-escalation study to evaluate the safety, tolerability, and clinical activity of a single dose of JAG201 administered via intracerebroventricular (ICV) injection in pediatric and adult participants with SHANK3 haploinsufficienc…
Phase 1/2 • Sponsor: Jaguar Gene Therapy, LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New drug combo aims to control rare kidney cancer
Disease control Recruiting nowTo learn if giving tivozanib in combination with nivolumab can help to control advanced nccRCC.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Ready-Made immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis is a phase 1 study designed to evaluate the safety, tolerability, and antitumor activity of FT825 (also known as ONO-8250) with or without monoclonal antibody therapy following chemotherapy in participants with advanced human epidermal growth factor receptor 2 (HER2)-positiv…
Phase 1 • Sponsor: Fate Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Brain-Lining cancer in breast cancer patients: could a reservoir pump chemo directly to the target?
Disease control Recruiting nowThis is a prospective, multicenter, randomized controlled, open-label investigator-initiated clinical study to evaluate the clinical efficacy and quality of life of intrathecal chemotherapy through Ommaya reservoir in combination with systematic chemotherapy versus systemic chemo…
Phase 4 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New pill shows promise against fatty liver disease in Mid-Stage trial
Disease control CompletedA double-blind placebo controlled, randomized, Phase 2b study to evaluate the efficacy and safety of once-daily, oral administration of 80 or 160 mg HSK31679 versus matching placebo in Patients With Non-Alcoholic Steatohepatitis (NASH) and Fibrosis.
Phase 2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for frail lymphoma patients: drug combo shows promise
Disease control Recruiting nowTo learn if adding epcoritamab to the treatment combination R-miniCVP (rituximab, cyclophosphamide, vincristine, prednisone) can help to control newly diagnosed DLBCL. The safety of this combination will also be studied.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New study tailors amyloidosis therapy based on genetic marker
Disease control Recruiting nowAchievement of complete hematologic response (CHR) is vital for systemic AL amyloidosis. Currently, the CHR rate of daratumumab, bortezomib, and dexamethasone (DBD) is close to 60%. Considering that Bcl-2 inhibitor is effective for AL amyloidosis with t(11; 14) and the median hem…
Sponsor: Jin Lu, MD • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Can a virtual escape ease the pain of knee surgery?
Symptom relief CompletedKnee osteoarthritis, which occurs after degeneration of the knee joint with age, is common in women after 65 years of age and surgical methods are generally used in the treatment of deformity, pain and limitation of movement. This surgical procedure is different from other surgic…
Sponsor: Sennur Kula Şahin • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Could a Late-Stage clot removal save mild stroke patients from worsening?
Disease control Recruiting nowEndovascular therapy (EVT) added on best medical management is currently recommended in acute large vascular occlusion (LVO) stroke patients with National Institutes of Health Stroke Scale (NIHSS) score \>5. Thus, a sizeable fraction of patients with a minor stroke that do not un…
Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug shows promise for tough brain cancers
Disease control OngoingThis phase II trial tests how well erdafitinib works in controlling IDH-wild type (WT), FGFR-TACC gene fusion positive gliomas that have come back after a period of improvement (recurrent) or that are growing, spreading, or getting worse (progressive). Erdafitinib is in a class o…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Sound waves zap kidney tumors in new Non-Invasive trial
Disease control OngoingThe purpose of this trial is to evaluate the effectiveness and safety of the HistoSonics Edison System for the destruction of kidney tissue by treating primary solid renal tumors.
Sponsor: HistoSonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC